<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "DTD/xhtml1-transitional.dtd" >
<html>
<head>
   <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"/>
   <meta name="AUTHOR" content="Martin"/>
   <title>Demo data: CDK1CyclinBCKS2</title>
<link rel="stylesheet" type="text/css" href="../../docs/ccp4i2.css" title="CCP4i2" />
<link rev="made" href="mailto:ccp4gui@ccp4.ac.uk" />
<style type="text/css">
h2 {
    color:#0077aa;
    font-family: "Helvetica Neue", Helvetica, "Liberation Sans", Arial, Sans-Serif;
}
p {
    font-size: 18px;
}
li {
    font-size: 16px;
}
</style>
</head>
<body>

<h1>CCP4i2 Tutorial: Inhibitor-bound ternary complex of CDK1, Cyclin B1 and CKS2</h1>

<p>A ternary complex of CDK1 bound to Cyclin B1 and CKS2, bound to a pyrazole inhibitor

<h2>Data files</h2>
<ul>
<li><a href="./1hck.pdb">1hck.pdb</a> Chain A is monomeric CDK2, i.e. inactive conformation</li>
<li><a href="./1jst.pdb">1jst.pdb</a> Chain A is CDK2 in complex with Cyclin A, i.e. in active conformation</li>
<li><a href="./1buh.pdb">1buh.pdb</a> CKS1 in complex with CDK2</li>
<li><a href="./2b9r.pdb">2b9r.pdb</a> Chains are all human cyclin B1</li>
<li><a href="./CDK1CyclinBCKS2Compound23.mtz">CDK1CyclinBCKS2Compound23.mtz</a></li>
<li><a href="./P06493.fasta">P06493.fasta</a> Sequence of human CDK2: crystallised species had an N-terminal GPLGS proteolysis artefact</li>
<li><a href="./P14635.fasta">P14635.fasta</a> Sequence of human Cyclin B1: crystallised species was untagged residues 175-432</li>
<li><a href="./P33552.fasta">P33552.fasta</a> Sequence of human CKS2: crystallised species added a C-terminal hexahistidine tag</li>
The ligand for this structure looks as follows: <br/>
<img src="./Structure.png"/>
</ul>

<address></address>
<!-- hhmts start -->Last modified: Thu Feb 26 14:37:05 GMT 2015 <!-- hhmts end -->
</body>
</html>

